Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critica...See more
Headquarter United States of America |
Countries of operation United States of America, Australia, Singapore, ... See more |
Year founded 2018 (6 years) |
Funding status Series C |
Company type MNC / Large Enterprise |
Director of Government Affairs, Merket Access and International Business SEA
Director, Clinical Research and Clinical Operations Head
Country Manager
The company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Director of Government Affairs, Merket Access and International Business SEA | - | hidden.item | hidden.item | hidden.item | ||
Director, Clinical Research and Clinical Operations Head | - | hidden.item | hidden.item | hidden.item | ||
Country Manager | - | hidden.item | hidden.item | hidden.item |
Auditor: | RSM SG ASSURANCE LLP |
Revenue: | hidden.item |
Corporate-only access Contact us for a free demo now! | |
Sign up to view for free |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 22 Nov 2018 | Singapore | SGD 290,822,300 | 46461: WHOLESALE OF MEDICINAL AND PHARMACEUTICAL PRODUCTS (WESTERN) |